Evaluation of the Use of AZD6244 to Induce Increased ER Expression and Anti-Estrogen Response in ER-Negative/Low Breast Cancer

NCT01313039 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
4
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Miami